WallStreetZen

NASDAQ: BIOT
Biotech Acquisition Co Stock

$9.70+0.01 (0.10%)
Updated Jun 17, 2021
BIOT Price
$9.70
Fair Value Price
N/A
Market Cap
$278.88M
52 Week Low
$9.54
52 Week High
$10.95
P/E
N/A
P/B
55.77x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
3.85
Operating Cash Flow
N/A
Beta
0.13
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
6
Industry average

Reasons for this score

BIOT is good value based on its book value relative to its share price (55.77x), compared to the US Shell Companies industry average (101.4x)
Valuation
BIOT's short-term assets ($1.50M) exceed its short-term liabilities ($91.65k)
Financials
BIOT's long-term liabilities ($19.15M) exceed its short-term assets ($1.50M)
Financials

1 of 2

BIOT News

Valuation

BIOT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0x
Industry
-22.84x
Market
26.15x

BIOT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
55.77x
Industry
101.4x
BIOT is good value based on its book value relative to its share price (55.77x), compared to the US Shell Companies industry average (101.4x)
Valuation

BIOT's financial health

Profit margin

Revenue
$0.0
Net Income
$2.5M
Profit Margin
0%

Assets to liabilities

Assets
$231.5M
Liabilities
$19.2M
Debt to equity
0
BIOT's short-term assets ($1.50M) exceed its short-term liabilities ($91.65k)
Financials
BIOT's long-term liabilities ($19.15M) exceed its short-term assets ($1.50M)
Financials
BIOT's debt to equity ratio (3.85) is considered high
Financials

Cash flow

Operating
-$864.7k
Investing
-$230.0M
Financing
$231.5M

Biotech Acquisition Stock FAQ

What is Biotech Acquisition's quote symbol?

(NASDAQ: BIOT) Biotech Acquisition trades on the NASDAQ under the ticker symbol BIOT. Biotech Acquisition stock quotes can also be displayed as NASDAQ: BIOT.

What is the 52 week high and low for Biotech Acquisition (NASDAQ: BIOT)?

(NASDAQ: BIOT) Biotech Acquisition's 52-week high was $10.95, and its 52-week low was $9.54. It is currently -11.42% from its 52-week high and 1.68% from its 52-week low.

How much is Biotech Acquisition stock worth today?

(NASDAQ: BIOT) Biotech Acquisition currently has 28,750,000 outstanding shares. With Biotech Acquisition stock trading at $9.70 per share, the total value of Biotech Acquisition stock (market capitalization) is $278.88M.

Biotech Acquisition stock was originally listed at a price of $10.31 in Jan 26, 2021. If you had invested in Biotech Acquisition stock at $10.31, your return over the last 0 years would have been -5.92%.

How much is Biotech Acquisition's stock price per share?

(NASDAQ: BIOT) Biotech Acquisition stock price per share is $9.70 today (as of Jun 17, 2021).

What is Biotech Acquisition's Market Cap?

(NASDAQ: BIOT) Biotech Acquisition's market cap is $278.88M, as of Jun 18, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biotech Acquisition's market cap is calculated by multiplying BIOT's current stock price of $9.70 by BIOT's total outstanding shares of 28,750,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.